| 标题 |
Remission of TP53 -Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33) 用Trem-Cel(一种缺乏CD33的CRISPR/Cas9基因编辑的同种异体移植物)移植后TP53突变型AML的缓解,随后移植供体来源的抗CD33嵌合抗原受体T(VCAR33)
|
| 网址 | |
| DOI | |
| 其它 |
期刊:JCO Precision Oncology 作者:Guenther Koehne; Muhammad U. Mushtaq; Lori S. Muffly; Manuel Menes; Jacques Azzi; et al 出版日期:2025-10-24 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |